169. メンケス病 ［臨床試験数：5，薬物数：5（DrugBank：4），標的遺伝子数：0，標的パスウェイ数：0］
Searched query = "Menkes disease"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04074512 | August 29, 2019 | 16 September 2019 | Copper Histidinate Treatment for Menkes Disease | Copper Histidinate Treatment for Menkes Disease | Menkes Disease | Drug: Copper Histidinate | Cyprium Therapeutics, Inc. | Not recruiting | N/A | 6 Years | All | Phase 4 | |||
| 2 | JPRN-UMIN000030626 | 2014/11/28 | 2 April 2019 | Investigation on the effectiveness of histidine copper treatment of Menkes disease patients | Menkes disease | Weekly,subcutaneous injection of histidine copper (750microgram once) is performed three times per week.It is continued every week until the end of the research during the research period. | Hamamatsu University School of Medicine | Not Recruiting | Not applicable | Not applicable | Male and Female | 2 | Not selected | Japan | ||
| 3 | JPRN-UMIN000005259 | 2011/03/03 | 2 April 2019 | Clinical trial of histidine-copper and diethyldithiocarbamate combination therapy for patients with Menkes disease | Menkes disease | give a dose of copper-histidine and diethyldithiocarbamate | Kobe Unniversitu Graduate School of Medicine | Not Recruiting | Not applicable | Not applicable | Male and Female | 2 | Not selected | Japan | ||
| 4 | NCT00811785 | February 27, 2009 | 26 August 2019 | Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency | Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency | Menkes Disease;Occipital Horn Syndrome;Unexplained Copper Deficiency | Drug: Copper Histidine | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | National Center for Complementary and Integrative Health (NCCIH) | Not recruiting | N/A | 80 Years | All | 93 | Phase 3 | United States |
| 5 | NCT00001262 | June 1990 | 19 October 2017 | Copper Histidine Therapy for Menkes Diseases | Early Copper Histidine Therapy in Menkes Disease | Kinky Hair Syndrome | Drug: Copper Histidine | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Not recruiting | N/A | N/A | All | 60 | Phase 1/Phase 2 | United States |